热门资讯> 正文
Nuvectis Pharma股价因1亿美元股票发行定价而下跌19%
2026-06-30 12:09
- Nuvectis Pharma (NVCT) had priced its underwritten public offering of 5M shares of its common stock at $20 per share, with expected gross proceeds of $100M, the company said Monday, sending shares down 19% in after-market trading.
- Nuvectis has also granted the underwriters a 30-day option to purchase up to 750,000 additional shares of its common stock at the public offering price, less underwriting discounts and commissions.
- The offering is expected to close on or about July 1. Nuvectis intends to use net proceeds from the offering to continue to advance the development programs of NXP100, NXP200, and NXP900 or any future product candidate.
- It also looks to also use proceeds for hiring additional personnel, capital expenditures, costs of operating as a public company, and other general corporate purposes.
More on Nuvectis Pharma
- Nuvectis Pharma, Inc. (NVCT) Discusses Strategic In-Licensing Deal and Expansion Into Complement-Mediated Diseases and Oncology Prepared Remarks Transcript
- Nuvectis Pharma announces public share offering to support drug programs
- Seeking Alpha’s Quant Rating on Nuvectis Pharma
- Historical earnings data for Nuvectis Pharma
- Financial information for Nuvectis Pharma
推荐文章
港股周报 | 科技股遭遇“黑色一周”！智谱、兆易创新周内分别重挫32%、28%；韩国去杠杆再掀芯片股风暴；“大空头”喊话布局港股
美股前瞻 | 抛售潮蔓延？纳指期货跌近2%，“恐慌指数”跳涨逾9%创周内新高；取消“星舰”试飞！SpaceX空头仓位大幅攀升
一周财经日历 | 超级财报周！特斯拉、英特尔、宁德将公布业绩；特朗普出席白宫记协晚宴，讲话或影响市场
华盛早报 | 存储概念遭抛售潮！SK海力士ADR暴跌13%；SpaceX星舰试飞取消股价破发；奈飞绩后跌逾9%
7月17日外盘头条：美国对伊朗发动新一轮打击 苹果拟对iPad mini进行升级 堪萨斯城联储行长称美国通胀过热
谷歌据悉推迟发布Gemini 3.5 Pro 因持续提升模型编程能力
闪迪股价持续下跌的背后原因
苹果拟对iPad mini进行五年来最大规模升级 今年秋季发布新品
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
